These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 28883260)

  • 41. Thyroid carcinoma after radioactive iodine therapy for Graves' disease.
    Ozaki O; Ito K; Mimura T; Sugino K; Kitamura Y; Iwabuchi H; Kawano M
    World J Surg; 1994; 18(4):518-21. PubMed ID: 7725738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.
    Tuttle RM; Lopez N; Leboeuf R; Minkowitz SM; Grewal R; Brokhin M; Omry G; Larson S
    Thyroid; 2010 Mar; 20(3):257-63. PubMed ID: 20187781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
    Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
    Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An unusual initial manifestation of metastatic papillary thyroid carcinoma: radioiodine uptake in lymph node metastatic lesions in a patient with Graves' disease.
    Newman SL; Griffith AY; Herbst AB; Yeh IT; Kukora JS
    Endocr Pract; 2002; 8(4):304-6. PubMed ID: 12173918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease.
    Joseph UA; Jhingran SG
    Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyroid carcinoma in patients with Graves' disease: an institutional experience.
    Wei S; Baloch ZW; LiVolsi VA
    Endocr Pathol; 2015 Mar; 26(1):48-53. PubMed ID: 25332114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metastatic follicular thyroid carcinoma to the thymus in a 35-year-old woman.
    Nam MS; Chu YC; Choe WS; Kim SJ; Hong SB; Kim YJ; Kim YS
    Yonsei Med J; 2002 Oct; 43(5):665-9. PubMed ID: 12402382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease.
    Cohen RZ; Felner EI; Heiss KF; Wyly JB; Muir AB
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):319-25. PubMed ID: 26656610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer.
    Louvet C; De Bellis A; Pereira B; Bournaud C; Kelly A; Maqdasy S; Roche B; Desbiez F; Borson-Chazot F; Tauveron I; Batisse-Lignier M
    Medicine (Baltimore); 2016 Nov; 95(48):e5474. PubMed ID: 27902601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary thyroid lymphoma associated with Graves' disease.
    Doi Y; Goto A; Murakami T; Yamashita H; Yamashita H; Noguchi S
    Thyroid; 2004 Sep; 14(9):772-6. PubMed ID: 15361265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
    Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Jan; 27(1):49-58. PubMed ID: 27750021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medullary thyroid cancer and Graves' disease.
    Schwartz RW; Kenady DE; Bensema M; McGrath PC; Flueck J
    Surgery; 1989 Jun; 105(6):804-7. PubMed ID: 2727903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioactive Iodine: A Living History.
    Daniels GH; Ross DS
    Thyroid; 2023 Jun; 33(6):666-673. PubMed ID: 37307104
    [No Abstract]   [Full Text] [Related]  

  • 54. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Follicular carcinoma of the thyroid and diffuse toxic goiter. Case report].
    Martínez-Delgado IA; Gómez-Martínez G; Ojeda-Ibarra JM
    Cir Cir; 2007; 75(3):213-6. PubMed ID: 17659173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgery still has a role in Graves' hyperthyroidism.
    Patwardhan NA; Moront M; Rao S; Rossi S; Braverman LE
    Surgery; 1993 Dec; 114(6):1108-12; discussion 1112-3. PubMed ID: 8256215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves' disease patients.
    Listewnik MH; Piwowarska-Bilska H; Jasiakiewicz K; Birkenfeld B
    Adv Clin Exp Med; 2021 Sep; 30(9):913-921. PubMed ID: 34418335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    Jin M; Jang A; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
    PLoS One; 2022; 17(3):e0265332. PubMed ID: 35275968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid nodules in Graves' disease: implications in an endemically iodine deficient area.
    Mishra A; Mishra SK
    J Postgrad Med; 2001; 47(4):244-7. PubMed ID: 11832639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.